Pacira BioSciences
PCRX
PCRX
214 hedge funds and large institutions have $3.29B invested in Pacira BioSciences in 2015 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 70 increasing their positions, 66 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 66
39% less call options, than puts
Call options by funds: $29M | Put options by funds: $47.5M
Holders
214
Holding in Top 10
11
Calls
$29M
Puts
$47.5M
Top Buyers
| 1 | +$72M | |
| 2 | +$56.7M | |
| 3 | +$43.8M | |
| 4 |
FAM
Fred Alger Management
New York
|
+$43.7M |
| 5 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$35.4M |
Top Sellers
| 1 | -$71.8M | |
| 2 | -$68.3M | |
| 3 | -$55.3M | |
| 4 |
VAM
Visium Asset Management
New York
|
-$50.7M |
| 5 |
Goldman Sachs
New York
|
-$37.6M |